Review of the Velpatasvir patent landscape: A scoping report
Review of the Pibrentasvir patent landscape: A scoping report
Review of the Glecaprevir patent landscape: A scoping report
Unitaid at 10: Celebrating 10 years of innovation in global health (mini)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: 2016 – 2019 Report (Dec 2016)
Global malaria diagnostic and artemisinin treatment commodities demand forecast 2016 – 2019: policy brief (Dec 2016)
Global malaria diagnostic and artemisinin treatment commodities demand forecast 2016 – 2019: forecasting methodology (Dec 2016)
Unitaid strategy 2017-2021
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Global malaria diagnostic and artemisinin treatment commodities demand forecast: 2017 – 2021 Report (May 2018)
Fever Diagnostic Technology Landscape
Multi-disease diagnostics landscape for integrated management of HIV, HCV, TB and other coinfections
Hepatitis C medicines technology and market landscape
Unitaid’s approach to intellectual property
Discussion Paper: Ensuring that essential medicines are also affordable medicines: challenges and options
Discussion Paper: An economic perspective on delinking the cost of R&D from the price of medicines
Unitaid and the Government of Spain
About Unitaid (Saving lives faster)
Unitaid and the UK Government
Unitaid audited financial report for the year ended 31 December 2023
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Unitaid audited financial report for the year ended 31 December 2022
Safeguarding – supplemental annex to Unitaid wrongdoing guidelines
FAQ – Financial Guidelines
Guidelines prevention, reporting and management of wrongdoing
Impact story: Expanding access to next generation drug-resistant tuberculosis treatment
Unitaid’s Impact 2017 Results and Key Performance Indictors
